Chronic myeloid leukemia (CML) is a clonal hematopoietic stem cell illness defined by oncogenic breakpoint cluster region–Abelson (BCR–ABL1) gene fusion [1]. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.